Failure to Achieve a Complete Remission (Univariate Logistic Regression)
| Variable . | RL . | OR . | 95% CI . | P . |
|---|---|---|---|---|
| Clinical | ||||
| Age | <60 | 1.97 | 0.72-.451 | .1800 |
| Gender | Female | 1.09 | 0.45-2.26 | .8291 |
| B-symptoms | Negative | 5.21 | 1.85-14.71 | .0020 |
| Stage III | I + II | 6.27 | 2.01-19.56 | .0017 |
| Stage IV | I + II | 8.80 | 2.69-28.73 | .0004 |
| Type | ||||
| NS | LP | 1.17 | 0.23-5.93 | .8423 |
| MC | NS | 1.83 | 0.35-9.47 | .5237 |
| LD | MC | 1.83 | 0.12-27.79 | .6662 |
| Immunohistochemistry | ||||
| CD 15 | Negative | 0.80 | 0.31-2.03 | .6490 |
| bcl.2 | Negative | 0.46 | 0.20-1.08 | .0734 |
| LMP1 | Negative | 0.63 | 0.27-1.47 | .2917 |
| Rb5-150 | 0 | 0.93 | 0.87-0.99 | .0316 |
| p535-150 | 0 | 0.92 | 0.81-1.05 | .2328 |
| Ki675-150 | 0 | 1.04 | 1.00-1.09 | .0316 |
| Variable . | RL . | OR . | 95% CI . | P . |
|---|---|---|---|---|
| Clinical | ||||
| Age | <60 | 1.97 | 0.72-.451 | .1800 |
| Gender | Female | 1.09 | 0.45-2.26 | .8291 |
| B-symptoms | Negative | 5.21 | 1.85-14.71 | .0020 |
| Stage III | I + II | 6.27 | 2.01-19.56 | .0017 |
| Stage IV | I + II | 8.80 | 2.69-28.73 | .0004 |
| Type | ||||
| NS | LP | 1.17 | 0.23-5.93 | .8423 |
| MC | NS | 1.83 | 0.35-9.47 | .5237 |
| LD | MC | 1.83 | 0.12-27.79 | .6662 |
| Immunohistochemistry | ||||
| CD 15 | Negative | 0.80 | 0.31-2.03 | .6490 |
| bcl.2 | Negative | 0.46 | 0.20-1.08 | .0734 |
| LMP1 | Negative | 0.63 | 0.27-1.47 | .2917 |
| Rb5-150 | 0 | 0.93 | 0.87-0.99 | .0316 |
| p535-150 | 0 | 0.92 | 0.81-1.05 | .2328 |
| Ki675-150 | 0 | 1.04 | 1.00-1.09 | .0316 |
Abbreviation: OR, odds ratio.
Rb, p53, and Ki67 expression was analyzed as continuous variables.